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Abstract
Negative pressure wound therapy (NPWT) provides proven wound healing benefits and is often a 
desirable wound treatment. Unfortunately, NPWT devices are not widely available in low-
resource settings (LRSs). In order to overcome identified NPWT barriers, a simplified NPWT 
(sNPWT) system was designed and iteratively improved during field-based testing. The sNPWT 
technology, our device design iterations, and the design-based results of our field tests are 
described. The sNPWT system includes a bellows hand pump, an occlusive drape, and a tube with 
tube connectors, connecting the drape to the pump. The most critical property of a sNPWT system 
is that it must be airtight. The details of the design iterations needed to achieve an occlusive 
system are explained. During the design process, the sNPWT system was tested during the 
earthquake relief in Haiti. This testing found that a liquid sealant was necessary to seal the drape 
to the peri-wound skin. A study conducted in Rwanda verified that a liquid latex sealant was safe 
to use and that the tube connector must be connected to the drape with an airtight method during 
the manufacturing process. This work has shown that sNPWT is feasible in LRSs. Since the 
completion of the clinical testing, the design has been further evolved and the developers are 
working with contract manufactures to produce the final design and preparing for regulatory 
approval applications.
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Introduction
Negative pressure wound therapy (NPWT) is the application of a controlled vacuum to a 
wound cavity. It has been clinically demonstrated to speed the healing time of open wounds 
by a factor of two or more and to aid in complete recovery with less scar tissue.1–3 In the 
field setting, NPWT allows for early wound management with wound stability during 
patient transport. In the clinical setting, its healing benefits promote active healing. 
Commercial NPWT devices have been available on the market since 1995, and today, there 
are over 35 different devices available. These devices are typically based-on the same 
engineering principles and are limited by high cost, high electrical power requirement, 
training needed for their complex computer interfaces, and lack of portability. With these 
limitations, currently devices are not widely available in low-income communities (LICs) 
and low-resource settings (LRSs).
In order to create a NPWT device applicable for use in LICs and LRSs, we identified key 
functional requirements for a simplified NPWT (sNPWT) device: easy-to-use, inexpensive, 
portable, and mechanically powered. We further identified air leaks into the supposedly 
occlusive, electrical NPWT dressing systems as the key barrier to realizing these additional 
functional requirements.4, 5 To that end, devices have recently been described, which aim to 
eliminate air leaks into the system and provide mechanical therapy.6, 7 However, these 
devices have not overcome many barriers and remain limited in their use.
The device described herein, called the Wound-Pump, was developed to be a reliable, 
broadly-applicable, airtight, sNPWT system. The key component is a true airtight dressing, 
which is applicable to most wound types and body contours. This true occlusive dressing is 
attached to a mechanical bellows pump with a plastic tube; all connections are airtight. The 
bellows serves as both the vacuum source and the wound exudate receptacle, minimizing the 
number of components, complexity, and cost.4 As a result, our mechanical system satisfies 
all sNPWT and general NPWT functional requirements.8
The Wound-Pump
Pump
As specified by the FDA, the NPWT vacuum source functional requirement is the ability to 
deliver a pre-set vacuum pressure to the wound bed.8 Therefore, the pump embodiment must 
have a deterministic behavior. Potential sNPWT pump embodiments were researched and 
narrowed down to two hand pumps: a plastic bellows pump and a plastic bulb pump, such as 
a Jackson-Pratt drain.5 Both of these are easy-to-use, inexpensive, portable and 
mechanically powered. However, the vacuum delivered by the bulb pump is highly variable 
and cannot be easily determined in real time without sensors. The pressure is largely 
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dependent on how the user squeezes the bulb,5 which causes a very inconsistent vacuum 
application that is not desirable for NPWT.
The second option, a plastic bellows often seen used as a toilet plunger, was proven to have 
a deterministic behavior for simple, hand-powered operation. A plastic bellows pump 
behaves like a linear spring4, 5 and the compression length of the bellows directly 
determines the vacuum pressure applied by the pump. At full compression, the pump applies 
maximum vacuum pressure, which degrades linearly to zero as the pump expands. The user 
has to simply compress the bellows by-hand to activate vacuum pressure. A pre-set vacuum 
pressure to the wound can be delivered by compressing the bellows to the desired length. 
The pressure can be monitored throughout therapy by measuring the length of the bellows 
and converting it to its corresponding pressure. If there is no air leak into the system, the 
pump will expand over time with the collection of exudate; therefore, a drop in vacuum 
pressure is purely determined by the rate of exudate removal from the wound. Between 
dressing changes, the pump must be monitored, exudate emptied and bellows recompressed, 
as needed, in order to stay within a predetermined pressure range.
The bellows pump design also plays a significant role in patient safety. Patient 
exsanguination has previously been reported due to ruptured blood vessels during NPWT.9 
This exsanguination is preventable with the bellows pump design, where the pump also 
serves as the exudate collection container. As blood fills the system, the pump physically 
expands, serving as an instant, visible alarm. Since the bellows has a limited internal 
volume, vacuum will stop after the bellows is fully expanded. Ideally, for sNPWT design, 
the internal fluid collection volume capacity should be limited to a safe amount of blood 
volume to remove from a patient.4 If necessary, pump expansion limiting components can 
be used to limit the expansion length of the pump.5 With its expansion characteristics and 
limited, closed volume, safety from exsanguination is inherently built into the bellows pump 
design.
Dressing
sNPWT dressings consist of three main components: (1) porous, non-adhesive packing 
material used to fill the wound cavity (e.g., sterilized sponge or gauze); (2) transparent 
occlusive cover placed over the porous dressing and adhered to the skin with a true 
occlusive seal; and (3) airtight connection mechanism to connect the dressing to the vacuum 
pump (i.e., typically tube connectors and tube). These dressing components are identical to 
NPWT dressings, other than the transparent cover must be truly occlusive for sNPWT, 
eliminating all air leaks. In general, NPWT dressings allow over 1 L/min of air to leak into 
the system, which is not feasible for a hand pump system.4 All three components are 
disposables, which are changed during each wound dressing change.
Porous Packing Material—The porous wound-packing material is the interface material 
between the vacuum source and the wound bed. Exudate flows from the wound bed through 
the packing material and tube to the collection container. Open-cell polyurethane foam is the 
most common material used in NPWT systems. Studies have shown that the design of the 
packing material influences the wound healing rate, focusing on the pore size in foam.10 
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There have also been adverse events associated with foam dressings, including many of the 
12 deaths and 174 injuries reported to the FDA from 2007 to 2011. These events were 
mostly due to the ingrowth of tissue into the pores of the foam, which caused tissue to tear 
and/or pieces of foam to be left in the wound cavity upon dressing removal.11 Gauze 
dressings have shown positive results in NPWT,2, 12 but have not been studied to the same 
degree as foams.13 In addition, sterile gauze is inexpensive and readily available in most 
wound care settings, including those in LICs and LRSs. Therefore, gauze is the Wound-
Pump packing material.
Occlusive Cover—The key component of the Wound-Pump is our occlusive drape that 
adheres to the skin in an airtight fashion (Figure 1). It consists of a thin carrier that is coated 
with skin contact adhesive. This drape provides a protective cover over the wound cavity 
and gauze packing material and remains airtight for its entire dressing period, which we 
targeted to be three days. This is a difficult property to achieve, as: (1) any wrinkles in the 
skin or drape are potential air leak paths into the system, (2) the surface of the skin 
inherently has wrinkles and hairs; and (3) when applying a planar drape to the contours of 
the body, wrinkles in the drape are often unavoidable, due to a geometry mismatch. In order 
to overcome these challenges, we developed a liquid sealant component, based on results 
from the lab and our work in Haiti (discussed below). We adhered the drape to the peri-
wound skin and then, sealed the edges of the drape to the skin using three, thin coats of 
liquid latex sealant. Successful, occlusive properties for sNPWT can be achieved with this 
sealant method, when combined with a drape capable of long-term wear.14 A phase 1 study 
in Rwanda (further discussed below) verified this sealant method in the clinical setting, as 
the drape was further refined. Material and thickness of the drape component (both carrier 
and adhesive) were iterated in real time based on adhesion performance, including the 
ability to accommodate for different skin types and large body movements. This was to 
increase its wear time for all wound sizes and locations. Iterations of the drape component 
are described in Zurovcik 2012.
Connection Mechanism—The tube connection method to the drape is also critical in 
achieving an airtight seal.5, 14 During the Wound-Pump phase 1 study in Rwanda, two tube 
attachment methods were explored: (1) not manufactured in an occlusive fashion to the 
drape prior to dressing application (Dressing Design A) and (2) manufactured with an 
occlusive attachment method to the drape (Dressing Design B).14 For Dressing Design A, 
the tube connector was sealed by the user with liquid latex sealant after the drape 
application. Dressing Design B sealed the tube connector with the liquid latex sealant during 
the manufacturing process, and therefore, only the edges of the drape were sealed after its 
application.
For both Dressing Design groups, the tube connector design varied, as detailed in Zurovcik 
2012. It was iterated in real time based on performance metrics, targeting: airtight 
connection, ease of application, fluid transport, and patient comfort. The original tube 
connector design (n = 10 dressings) for the phase 1 study is included in Dressing Design A. 
It sealed the tube using only the adhesive drape and liquid latex sealant. Its performance 
proved that a tube connector component is necessary to achieve repeatable, occlusive 
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performance.14 Therefore, a custom component was designed (Figure 1) that was iterated in 
shape, size, and tube end effects during the phase 1 study. In this embodiment, the tube was 
attached to a flexible flange in an airtight manner during the manufacturing process. Then, 
the flange was subsequently attached to the drape using variable attachment designs within 
the two, different Dressing Design A and B groups.
Clinical Applications
The iterative Wound-Pump dressing design was driven by the results of field applications in 
Haiti and in Rwanda. Table 1 outlines the design flow of the dressing to overcome air leaks.
Earthquake Relief Effort—The earthquake on January 12th, 2010 in Haiti resulted in an 
epidemic of acute wounds. A team of four clinicians was deployed to assist with wound care 
at Hôpital de l'Université d'état d'Haiti in Port-au-Prince and brought several Wound-Pump 
devices with them, since the lack of electricity hindered the use of donated electrical NPWT 
devices. The Wound-Pump system consisted of the bellows pump and the first iteration of 
our occlusive medical drape. The liquid latex sealant component was not used, and the tube 
was manufactured with an occlusive attachment to the center of the drape.14 Sterilized gauze 
available on-site was used for the wound packing material. With a strict screening process, 
therapy was applied to five patients.
As the mission in Haiti was purely humanitarian, only general results are reported. The 
Wound-Pump treated wounds were clean and granulating during the two week deployment.4 
The limited application of the Wound-Pump verified that an additional liquid sealant was 
necessary. An occlusive seal was possible to achieve without the sealant; however, it had 
limited application to a small subset of wounds and was not always repeatable between 
dressing changes.
Phase I Study—The phase 1 study was a prospective single-arm investigation of the 
biomechanical parameters and adverse events associated with the Wound-Pump system in a 
LRS.15 The study took place at two hospitals in Rwanda: Rwinkwavu Hospital and 
University Teaching Hospital-Kigali (CHUK). In this study, liquid latex sealant was used to 
seal the edges of the drape to the periwound skin. Two tubing attachment methods, as 
described above were explored. Sterilized gauze available on-site was used for the wound 
packing material. Forty-two wounds on 37 patients were treated in this study.15
Seventy-one dressings were analyzed for occlusive performance. The average time to 
occlusive failure was 22.2 hours (sd 27.0, range 0 to 72 hours): Dressing Design B (31.7 
hours, sd 30.2, n = 37) and Dressing Design A (11.8 hours, sd 18.6, n = 34) (p = 0.003).15 
Further analysis verified that the large standard deviations are expected due to high 
variability in the data. This is due to many factors, including variation of the dressing 
designs in each group and variety of treated wound locations and sizes.15 Despite this 
variability, these data results helped to drive the design path; Dressing Design B 
outperformed Design A, which proved that the tube connector must be connected to the 
dressing in an airtight fashion during the manufacturing process.
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Dressing Design B was analyzed further by wound location: the Wound-Pump system 
remained occlusive for more than two days on easy-to-dress wounds (52.7 hours, sd 29.3, n 
= 11) and for one day on more difficult to dress wounds (medium: 33.0 hours, sd 36.4, n = 4 
and hard: 20.9 hours, sd 24.7, n = 22) (p = 0.029).15 This indicated that further dressing 
iterations were necessary to account for increased body contours. In addition, no serious 
adverse events were encountered,15 which verified the Wound-Pump safety in the clinic and 
LRSs.
Conclusions
sNPWT provides a feasible and safe NPWT solution in LICs and LRSs, including disaster 
relief environments. In these settings, two main benefits are: 1) clinicians can treat more 
patients, as the sNPWT dressings need to be changed approximately every three days versus 
one to two times per day for standard wet-to-dry dressings; and 2) wounds may close faster 
in an environment where infection risk is extremely high.16 Since the completion of the 
clinical study in Rwanda, the Wound-Pump dressing has been further evolved and is 
currently undergoing contract manufacturing for future clinical trials, commercialization, 
and regulatory approvals.
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Figure 1. 
Left: The Wound-Pump dressing utilizes an occlusive adhesive drape that is sealed with a 
liquid sealant border over the gauze packing material to the peri-wound skin. The drainage 
tube is connected to the drape with a flexible tube connector, which is manufactured with an 
air-tight process.
Right: The drainage tube is connected to the bellows pump with airtight connectors. The 
bellows pump also serves as the exudate collection container.
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